China’s New Drug Procurement Program Shakes Up Big Pharma
The new bidding system for generic drugs upends the business of global drug makers in China. The big winners have been Chinese drug makers.
Showing 1657 - 1668 of 1857
Meet the Military Affiliates
Trump’s November executive order branded 31 companies as having ties to the People’s Liberation Army. Who are they, and who has stakes in them?
China Can Spend More to Grow More
Despite growth, China’s economy still faces serious challenges, which can only be addressed with a more expansionary fiscal policy.
Mining’s Makeover
For more than a decade, the U.S. has been sounding the alarm about China’s stranglehold on rare earths. Now with new investments and new operations...
Mining the Details
This week, we’re clarifying supply chains and mail logistics.
Delivering China’s Mail
How did USPS end up subsidizing China’s e-commerce?
China Books for a New President
Making sense of the many challenges Biden faces.
SoftBank’s Betting on China — and the U.S.
The Japanese investment fund has bet heavily on startups in the U.S. and China.
Kevin Rudd Calls B.S. on U.S.-China ‘Cold War’
Definitions matter, says the former Australian PM.
China’s Solar Push
China makes most of the world’s solar panels. But its state policy banks seem reluctant to finance overseas solar projects. Why?
Eric X. Li on China’s Success, America’s Failure and the Irrational Rivalry
The Shanghai-based venture capitalist says America is in decline, and that China’s political system has delivered — but don’t call it authoritarian.
Mr. China
Jerome A. Cohen pioneered the study of Chinese law in the United States. He met with Zhou Enlai, trained Chinese officials and helped American firms...